hg_150860.1

Basic information about the TSS

---

TSS ID: hg_150860.1 Species: human Chr: chr15		Start: 73633310 End: 73633432 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000345330.9 BC105979 AK129908 BC067828 AF109126 AF109127 AB209812 Distance: 0 GeneID: 27020 HGNC/MGI_ID: HGNC:17867 UniProt_ID: Q9Y639

Gene_name: neuroplastin Gene_symbol: NPTN Gene_synonyms: GP55 GP65 SDR1 np55 np65 Gene_source: HGNC:17867

TATA-Box annotation

---

Distance to TSS:	18
Nearest PromoterID:	NM_001161364
Entrez ID:	27020
Nearest Unigene:	Hs.744867
Nearest Refseq:	NM_012428
Nearest Ensembl:	ENSG00000156642
Gene Name:	neuroplastin
Gene Alias:	GP55|GP65|SDFR1|SDR1|np55|np65
Gene Description:	neuroplastin
Gene Type:	protein-coding
CpG%:	0.135
GC%:	0.746269
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NPTN p2@NPTN p3@NPTN p4@NPTN p5@NPTN
Sample		p1@NPTN	p2@NPTN	p3@NPTN	p4@NPTN	p5@NPTN
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	31.17	36.62	3.12	1.17	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	28.12	38.04	3.84	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	29.90	42.44	3.86	0.39	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	23.08	39.92	2.70	0.21	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	29.47	37.79	2.02	0.45	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	26.75	42.64	1.55	0.58	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	31.16	28.98	6.10	0.44	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	24.71	26.89	4.60	0.24	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	27.78	28.64	3.85	0.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	28.40	37.10	4.06	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	36.79	32.74	6.06	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	31.30	32.12	5.29	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	29.98	10.80	2.26	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	27.81	11.73	1.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	24.37	11.42	1.98	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	26.91	11.07	2.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	23.81	6.33	2.62	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	18.98	8.01	3.80	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	23.46	5.86	3.73	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	30.24	10.53	1.81	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	26.73	10.69	1.87	0.27	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	25.20	10.53	2.59	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	25.33	7.24	2.20	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	21.35	9.46	1.21	0.73	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	19.87	11.09	2.32	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	22.47	11.08	2.53	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	23.08	8.24	5.49	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	28.53	7.07	1.41	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	23.58	11.79	1.62	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	25.88	13.21	1.45	0.36	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	27.84	10.68	2.72	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	22.86	10.16	2.15	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	22.37	6.54	2.32	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	22.43	9.90	2.31	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	25.99	9.16	2.24	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	25.68	10.54	2.87	0.96	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	31.68	10.63	2.66	0.61	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	25.79	11.69	3.43	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	26.74	9.99	1.89	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	29.29	8.88	1.92	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	24.00	8.00	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	18.01	11.42	1.61	0.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	23.62	8.86	2.32	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	22.90	8.92	2.45	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	30.72	9.03	1.41	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	30.94	8.84	4.65	1.16	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	32.39	6.00	2.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	30.40	6.56	1.79	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	27.29	9.34	4.31	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	21.64	9.50	2.43	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	21.93	9.43	2.66	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	22.02	10.45	4.45	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	55.97	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	21.29	15.61	1.42	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	15.91	9.28	1.66	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	27.68	9.23	5.03	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	18.83	5.97	1.84	1.84	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	15.56	15.23	1.94	2.27	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	18.31	13.17	2.57	0.64	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	19.49	6.92	2.83	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	16.22	11.99	2.82	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	14.58	15.70	0.56	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	54.93	11.94	7.17	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	17.33	11.89	2.04	1.02	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	21.44	22.74	2.27	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	25.91	29.46	1.42	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	64.66	48.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	63.18	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	33.64	32.18	2.44	1.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	26.78	39.17	1.98	0.99	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	23.92	35.65	2.35	0.00	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	35.11	23.51	1.66	0.99	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	27.22	33.41	2.17	2.47	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	36.08	26.91	0.61	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	51.32	115.30	4.75	0.79	0.16
Adipocyte - breast, donor2	11327-117E4	42.67	78.13	5.13	2.09	1.12
Adipocyte - omental, donor1	11473-119C6	60.31	130.03	6.87	0.89	0.25
Adipocyte - omental, donor2	11474-119C7	50.08	120.35	3.74	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	59.62	130.95	5.02	1.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	53.59	162.05	5.10	2.55	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	30.79	27.49	2.20	2.20	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	19.87	14.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	18.07	11.99	1.22	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	40.87	61.61	4.69	0.20	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	27.54	42.72	5.40	0.77	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	37.08	44.32	3.07	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	41.15	55.25	2.94	0.00	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	35.15	49.14	2.09	0.24	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	28.40	37.76	1.94	0.65	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	19.19	44.79	1.60	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	23.93	39.51	1.67	0.56	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	21.63	50.74	0.83	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	21.35	33.66	2.76	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	15.05	38.94	0.98	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	17.05	31.67	3.04	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	40.66	12.82	3.31	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	12.19	3.59	1.08	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	9.58	3.59	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	34.72	10.97	2.52	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	31.80	6.69	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	33.90	6.78	1.85	0.41	0.00
Anulus Pulposus Cell, donor1	11248-116E6	25.63	44.97	2.29	0.46	0.11
Anulus Pulposus Cell, donor2	11463-119B5	26.21	42.12	1.71	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	23.36	37.29	3.59	0.90	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	31.69	34.30	2.60	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	21.40	49.23	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	30.79	28.70	2.39	1.20	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	36.67	24.03	2.53	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	21.12	28.38	2.64	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	27.62	28.91	1.62	0.32	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	29.13	34.47	1.94	0.49	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	15.44	27.32	1.19	0.00	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	30.13	32.39	1.51	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	31.20	31.93	3.63	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	16.30	22.57	3.76	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	33.94	35.75	2.64	0.16	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	31.39	19.11	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	25.63	34.53	1.81	0.30	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	31.08	36.97	1.07	1.07	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	39.87	31.55	1.89	0.38	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	32.61	34.48	1.60	1.07	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	32.19	27.31	2.93	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	36.65	32.01	2.16	1.33	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	22.81	40.82	1.20	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	31.86	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	35.16	33.28	2.06	0.17	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	12.58	4.19	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	20.87	34.47	1.94	1.46	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	39.46	31.11	3.04	1.90	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	16.96	31.50	3.63	2.42	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	29.07	27.93	2.28	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	28.65	36.13	2.57	1.07	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	22.20	29.42	1.81	0.52	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	29.56	33.78	2.82	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	35.69	31.19	4.18	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	24.26	28.54	1.43	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	26.91	38.02	2.34	0.58	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	30.71	38.84	3.01	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	17.82	32.08	2.38	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	36.11	34.58	2.54	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	31.58	30.82	2.80	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	24.14	22.87	1.27	1.27	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	25.46	25.89	3.02	0.43	1.73
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	35.35	33.45	1.91	0.64	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	21.75	24.07	2.90	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	34.96	27.40	1.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	33.23	30.68	2.88	0.68	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	16.21	39.38	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	23.24	4.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	30.66	39.02	2.14	0.21	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	31.89	30.08	1.20	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	31.35	28.43	0.00	0.73	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	31.72	28.74	2.76	1.84	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	28.05	22.95	5.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	33.56	42.20	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	34.48	36.95	2.06	0.21	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	22.64	29.68	2.14	0.92	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	32.03	42.07	2.87	1.43	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	37.47	42.80	2.66	0.67	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	24.41	30.52	3.05	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	32.68	38.77	1.66	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	32.57	37.07	1.32	0.79	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	19.99	27.26	3.63	1.45	0.36
Astrocyte - cerebellum, donor1	11500-119F6	27.27	14.49	4.54	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	30.47	9.93	4.62	0.17	0.17
Astrocyte - cerebellum, donor3	11661-122F5	28.74	10.91	2.31	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	24.75	10.46	1.05	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	35.43	8.90	3.56	0.49	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	34.01	12.98	2.24	0.60	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	32.11	2.52	0.92	0.69	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	30.57	3.38	0.88	0.50	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	31.52	3.07	1.48	0.34	0.11
Basophils, donor1	12241-129G9	17.52	12.55	0.78	0.26	0.26
Basophils, donor2	12242-129H1	23.45	22.01	2.16	0.36	0.00
Basophils, donor3	12243-129H2	15.88	18.52	0.15	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	28.03	12.07	1.51	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	10.06	4.11	1.83	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	43.04	14.35	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	23.85	10.04	2.51	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	31.40	11.44	3.12	0.42	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	17.73	7.14	0.46	0.69	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	25.37	15.48	1.44	0.54	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	20.51	13.81	1.03	0.00	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	23.52	11.18	1.16	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	19.51	3.20	0.96	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	15.78	20.29	2.25	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	20.04	22.27	1.11	0.00	0.19
CD14+ Monocytes, donor3	11381-118B4	19.32	26.12	0.66	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	34.81	67.93	1.98	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	41.70	61.79	1.52	0.38	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	49.64	81.20	1.64	0.99	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	26.89	39.03	1.45	0.58	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	17.80	30.48	1.21	0.30	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	20.14	36.48	1.42	0.71	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	16.74	26.45	1.84	0.67	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	18.77	26.50	1.10	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	18.10	37.69	0.25	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	13.31	23.30	0.98	0.39	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	13.35	16.91	0.89	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	16.32	26.33	1.52	0.22	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	19.43	25.29	2.11	0.70	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	23.76	23.23	2.11	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	21.08	33.28	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	19.04	27.37	1.04	0.45	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	18.56	25.94	1.20	0.60	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	19.57	37.06	1.04	0.21	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	21.96	31.34	1.14	0.46	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	12.22	18.32	0.45	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	13.97	34.04	1.31	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	16.68	23.67	0.81	0.27	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	15.18	22.33	0.52	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	14.31	28.19	0.84	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	35.46	53.09	1.29	0.55	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	34.52	44.03	1.76	1.06	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	33.34	55.72	1.32	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	18.13	22.49	0.70	0.87	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	13.38	12.64	1.86	1.12	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	19.61	25.65	0.86	0.22	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	36.44	52.00	2.46	2.05	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	24.80	34.77	1.16	0.23	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	27.61	56.37	1.16	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	31.39	29.86	1.53	0.44	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	27.72	38.35	0.00	0.46	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	25.99	32.49	0.65	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	36.44	47.81	2.65	0.47	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	27.94	43.66	1.22	0.17	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	39.69	46.38	1.34	0.22	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	35.72	23.22	1.28	0.51	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	30.08	26.79	1.32	0.44	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	36.00	20.00	0.42	0.42	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	26.42	6.10	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	18.31	6.10	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	26.93	1.04	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	22.92	7.46	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	30.02	8.58	1.61	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	24.57	8.42	2.81	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	22.75	3.92	1.57	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	21.09	2.64	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	10.68	3.29	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	10.88	3.63	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	14.14	3.53	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	23.44	5.25	4.44	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	14.38	3.60	3.20	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	8.03	2.01	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	10.11	14.05	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	17.66	3.01	0.38	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	18.26	1.80	0.45	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	18.21	6.07	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	19.60	6.74	0.00	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	10.67	7.93	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	12.51	6.38	0.00	0.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	15.72	9.66	0.45	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	12.65	7.19	0.57	0.29	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	15.17	6.16	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	21.07	6.32	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	26.37	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	19.37	6.65	1.01	0.58	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	23.56	12.20	1.19	0.85	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	21.28	9.67	0.64	0.16	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	14.79	10.76	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	23.41	16.42	0.35	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	22.00	13.64	0.44	1.32	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	8.01	1.69	0.42	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	13.09	2.91	0.00	0.62	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	16.37	2.00	0.00	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	26.11	1.90	0.82	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	17.15	1.61	1.07	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	25.11	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	18.36	3.34	0.56	0.37	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	21.88	7.36	0.65	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	21.02	6.51	0.21	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	22.75	1.01	0.51	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	20.80	5.20	0.00	0.00	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	19.61	5.67	0.00	0.87	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	43.55	8.41	1.48	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	34.16	6.46	1.85	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	32.10	5.58	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	39.32	9.97	0.55	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	34.11	12.76	1.96	0.74	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	35.42	9.24	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	39.39	15.04	0.36	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	41.55	12.46	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	20.95	8.18	0.33	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	17.65	14.27	0.75	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	25.50	12.12	0.25	0.25	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	10.78	3.67	0.23	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	8.15	6.23	0.96	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	10.40	3.56	0.00	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	12.61	8.41	0.00	0.90	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	13.20	5.28	0.24	0.24	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	16.60	7.05	0.91	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	17.82	6.08	0.22	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	12.37	6.32	1.05	0.79	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	18.53	6.57	0.23	0.47	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	15.70	8.45	0.30	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	15.69	4.94	0.29	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	19.98	5.33	0.27	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	20.14	9.63	2.19	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	21.41	12.75	1.37	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	21.63	18.65	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	16.57	6.84	0.36	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	16.98	6.91	0.29	0.58	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	11.55	6.84	0.24	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	16.48	7.61	0.95	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	15.99	4.31	0.00	0.31	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	11.86	7.37	0.32	0.96	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	21.04	7.65	0.38	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	16.55	6.70	1.18	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	12.10	5.29	1.51	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	21.68	10.44	2.41	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	19.58	9.79	1.40	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	26.05	15.03	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	25.59	74.94	5.48	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	14.82	17.79	1.98	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	24.94	27.15	1.68	0.21	0.11
Chondrocyte - de diff, donor1	11261-116G1	32.93	123.07	1.39	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	24.17	64.68	2.49	0.00	1.42
Chondrocyte - de diff, donor3	11410-118E6	39.60	84.99	2.84	0.23	0.80
Chondrocyte - re diff, donor2	11339-117F7	71.62	122.65	4.48	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	51.76	93.82	1.62	0.81	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	39.71	13.54	2.41	0.46	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	48.95	23.09	4.49	0.86	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	44.43	17.08	2.39	0.71	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	77.95	74.09	6.88	0.64	0.37
Corneal Epithelial Cells, donor1	11526-119I5	26.35	4.17	1.54	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	23.89	5.69	3.41	2.28	0.00
Corneal Epithelial Cells, donor3	11687-122I4	50.36	8.18	4.35	0.26	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	52.50	49.20	1.16	0.33	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	62.45	50.78	0.95	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	48.31	62.11	6.90	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	56.91	31.96	0.76	1.08	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	23.57	6.15	0.34	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	21.54	6.53	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	21.78	9.19	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	17.84	16.51	0.67	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	20.54	14.08	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	25.73	22.91	2.83	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	20.84	14.94	3.15	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	27.63	21.23	1.75	0.58	0.00
Endothelial Cells - Artery, donor2	11341-117F9	27.06	24.47	0.71	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	26.30	22.79	0.53	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	22.61	11.30	1.11	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	29.21	17.04	0.91	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	34.67	31.29	1.41	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	17.83	33.87	2.08	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	12.50	18.74	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	25.66	30.48	1.84	0.28	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	24.81	40.01	2.80	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	23.59	17.82	1.57	0.52	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	28.70	23.23	1.37	0.12	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	23.25	16.51	2.61	0.43	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	36.64	17.46	3.54	0.12	0.12
Endothelial Cells - Vein, donor1	11267-116G7	12.51	12.51	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	12.57	14.67	1.40	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	22.45	18.21	1.10	0.16	0.16
Eosinophils, donor1	12244-129H3	30.49	30.49	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	49.51	66.01	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	42.80	117.71	10.70	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	27.61	6.84	1.22	0.00	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	20.80	4.16	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	16.27	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	54.19	114.53	5.75	1.64	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	25.62	22.88	2.96	1.64	0.88
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	6.61	2.60	0.76	0.00	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	36.75	47.18	2.30	0.24	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	54.86	33.57	2.87	0.14	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	34.70	32.80	4.75	0.84	0.95
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	88.53	110.93	10.54	1.05	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	45.18	34.55	2.99	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	47.18	63.51	0.91	1.81	1.36
Fibroblast - Cardiac, donor2	11345-117G4	34.11	38.66	2.27	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	57.57	55.52	2.68	0.47	0.32
Fibroblast - Cardiac, donor4	11452-119A3	33.95	33.34	4.55	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	28.93	31.73	2.28	0.63	0.25
Fibroblast - Cardiac, donor6	11460-119B2	30.77	33.35	2.88	0.61	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	35.51	27.74	3.48	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	26.75	32.36	1.29	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	45.41	14.65	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	15.91	2.54	2.77	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	16.11	27.14	1.70	0.34	0.17
Fibroblast - Dermal, donor1	11269-116G9	29.58	10.33	1.64	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	16.51	5.66	0.00	0.00	0.94
Fibroblast - Dermal, donor3	11418-118F5	35.06	20.91	1.57	0.12	0.24
Fibroblast - Dermal, donor4	11450-119A1	22.27	6.78	2.60	0.34	0.68
Fibroblast - Dermal, donor5	11454-119A5	21.46	10.29	5.23	0.52	0.17
Fibroblast - Dermal, donor6	11458-119A9	32.81	12.83	2.60	0.81	0.00
Fibroblast - Gingival, donor1	11237-116D4	24.57	26.65	0.62	0.00	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	39.56	57.90	3.67	1.05	0.52
Fibroblast - Gingival, donor2	11318-117D4	31.76	18.19	2.77	0.66	0.26
Fibroblast - Gingival, donor3	11394-118C8	30.36	31.33	2.51	0.48	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	43.63	90.38	2.08	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	48.98	66.43	2.29	1.06	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	44.90	47.55	3.74	0.31	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	39.08	56.93	5.14	0.95	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	63.17	34.58	4.59	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	34.95	71.37	2.49	0.29	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	28.50	49.36	3.82	0.68	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	37.41	49.25	4.28	0.66	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	29.20	71.61	3.82	0.44	0.15
Fibroblast - Lung, donor1	11270-116H1	23.11	10.87	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	25.37	16.41	5.97	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	35.88	18.99	2.32	0.42	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	48.32	19.99	1.67	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	34.97	15.38	0.00	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	17.63	7.28	1.12	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	52.37	34.91	3.25	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	7.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	59.56	5.96	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	27.54	15.71	3.30	0.19	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	41.41	14.11	4.10	0.61	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	37.64	31.52	2.45	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	53.43	93.12	4.58	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	56.43	76.95	2.70	1.62	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	52.07	78.28	3.94	0.35	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	34.15	44.99	2.76	0.22	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	64.41	39.22	2.84	0.61	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	29.40	15.37	3.34	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	30.44	23.72	2.37	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	70.25	188.13	5.75	1.59	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	36.59	80.46	2.66	0.18	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	44.54	65.24	3.35	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	95.97	182.62	6.32	1.20	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	33.79	63.48	2.37	0.54	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	39.23	105.79	3.54	0.25	1.01
Fibroblast - skin normal, donor1	11553-120C5	35.11	62.02	3.45	0.66	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	112.08	209.33	8.82	0.80	0.60
Fibroblast - skin normal, donor2	11561-120D4	58.67	111.31	3.32	0.80	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	51.98	111.22	4.84	0.60	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	34.46	68.68	2.49	0.66	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	25.81	62.06	1.37	0.68	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	122.18	271.94	11.82	1.31	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	66.36	123.78	3.62	2.13	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	53.30	67.64	4.05	0.34	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	31.83	45.16	1.10	1.41	1.25
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	66.48	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	45.32	97.61	4.36	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	52.18	41.09	2.77	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	79.63	49.71	2.34	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	63.88	33.98	1.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	21.44	13.78	9.19	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	17.87	23.61	8.93	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	43.07	15.69	9.70	0.29	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	45.50	15.72	7.72	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	32.88	17.81	7.08	0.91	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	54.88	13.67	12.68	0.59	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	42.03	17.97	10.04	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	30.66	17.94	5.54	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	53.07	11.06	15.04	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	31.37	20.07	6.36	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	35.83	27.21	5.91	0.49	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	30.09	23.10	5.37	1.34	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	35.68	25.52	3.35	0.25	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	36.82	28.52	5.12	0.28	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	33.54	27.24	4.88	0.41	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	30.80	27.15	3.19	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	28.40	31.76	3.61	0.75	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	40.87	34.75	8.52	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	32.21	20.09	2.07	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	28.45	29.57	3.66	0.32	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	40.44	30.39	4.69	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	24.20	12.10	2.62	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	24.43	20.36	4.41	0.68	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	40.35	32.28	2.31	0.44	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	25.39	11.97	1.14	0.00	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	21.35	12.98	3.07	0.00	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	29.88	17.04	2.21	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	32.45	26.79	2.91	0.08	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	28.18	32.67	2.86	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	33.83	17.33	2.48	0.41	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	27.44	17.99	1.50	0.35	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	33.19	16.51	2.33	0.83	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	26.89	15.21	1.54	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	27.80	18.69	1.97	0.37	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	28.53	18.15	2.27	0.65	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	27.26	16.36	1.60	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	26.53	14.69	1.80	0.38	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	25.15	13.76	1.58	0.63	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	31.93	14.60	2.43	0.30	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	29.90	18.09	1.99	0.73	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	23.93	19.32	1.98	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	38.72	15.99	1.12	1.12	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	31.02	21.76	1.85	0.37	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	27.81	20.32	4.01	0.53	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	30.91	18.05	2.45	0.15	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	28.37	22.28	2.07	0.52	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	30.36	22.77	2.71	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	28.94	24.52	2.58	0.74	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	28.95	27.19	2.63	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	39.67	30.74	0.99	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	40.23	30.21	2.37	0.53	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	37.33	36.52	1.61	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	35.33	30.75	2.54	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	35.03	21.90	10.55	0.80	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	35.44	20.95	8.63	0.46	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	45.42	19.84	8.39	0.61	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	29.42	15.96	4.07	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	15.54	16.67	4.52	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	35.51	17.06	3.69	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	19.80	32.17	9.90	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	31.72	26.30	3.48	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	40.11	40.11	3.21	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	39.99	33.04	6.96	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	28.64	28.97	3.58	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	39.12	26.36	3.29	1.24	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	23.33	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	28.24	29.08	4.75	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	31.70	33.01	4.90	0.98	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	35.23	21.81	5.03	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	32.44	28.31	3.50	0.64	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	30.23	31.25	3.40	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	25.06	18.79	2.09	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	26.34	25.20	4.01	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	21.31	24.57	2.96	0.30	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	13.55	28.80	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	29.41	46.39	2.07	2.49	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	24.85	28.54	1.38	0.69	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	47.42	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	26.52	29.98	3.08	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	26.73	38.14	3.59	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	26.75	28.09	3.34	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	30.82	20.03	1.16	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	33.89	55.12	4.45	0.34	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	27.33	27.33	0.00	4.97	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	19.82	19.82	1.89	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	31.99	22.93	2.41	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	27.98	26.96	2.03	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	28.32	17.95	1.60	0.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	25.65	29.60	1.48	0.49	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	31.87	20.07	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	27.42	28.59	1.75	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	16.24	18.43	2.63	1.32	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	20.34	33.91	0.85	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	31.64	54.92	1.79	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	27.66	40.76	0.49	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	31.96	35.38	2.28	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	39.50	29.94	2.91	1.25	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	21.36	19.12	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	19.35	22.20	1.59	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	17.13	10.44	2.09	0.00	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	30.29	11.60	4.06	0.46	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	26.67	13.34	4.56	0.34	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	31.17	7.96	2.05	0.46	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	26.12	9.84	2.62	0.44	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	29.66	13.75	3.65	0.43	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	25.19	8.61	2.58	0.22	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	26.90	12.70	3.74	0.25	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	22.64	13.55	4.12	0.17	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	24.35	9.61	1.28	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	19.59	10.07	2.80	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	27.27	11.25	2.60	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	15.86	7.93	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	25.40	22.93	2.12	0.00	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	11.62	12.35	1.45	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	23.43	18.53	3.32	0.00	0.17
Hepatocyte, donor1	11523-119I2	18.16	30.27	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	19.39	47.40	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	34.97	42.33	1.84	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	24.80	0.00	1.31	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	46.14	54.01	2.45	0.52	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	35.12	19.07	3.29	0.27	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	6.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	2.77	2.77	4.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	23.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	11.37	1.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	5.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	7.94	2.65	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	4.43	5.54	0.00	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	6.93	9.45	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	4.64	7.73	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	8.40	5.17	1.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	14.49	4.83	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	7.33	7.33	1.63	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	7.56	6.72	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	8.84	9.64	1.61	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	8.31	4.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	7.55	4.72	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	4.53	4.53	0.00	0.91	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	5.38	3.23	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	3.81	5.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	5.74	8.93	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	10.94	3.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	7.85	9.28	0.71	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	6.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	7.10	4.94	0.00	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	10.54	3.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	10.43	4.17	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.98	1.74	1.74	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	9.00	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	5.33	4.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	6.93	1.39	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	5.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	6.44	3.68	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	3.03	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	4.23	2.11	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	40.55	22.19	2.20	0.33	0.16
Keratinocyte - epidermal, donor2	11349-117G8	9.37	2.34	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	48.46	20.45	2.46	0.47	0.19
Keratinocyte - oral, donor1	11251-116E9	45.86	16.35	2.95	0.57	0.11
Keratocytes, donor1	11527-119I6	31.98	12.72	3.09	0.34	0.00
Keratocytes, donor2	11607-120I5	23.44	7.03	2.34	0.00	0.00
Keratocytes, donor3	11688-122I5	22.13	17.98	1.38	0.20	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	83.52	65.94	10.99	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	38.83	15.10	2.16	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	34.48	7.96	2.42	0.23	0.00
Lens Epithelial Cells, donor3	11690-122I7	64.78	52.27	4.34	0.10	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	19.45	17.31	0.83	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	8.93	9.21	0.56	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	18.42	23.30	1.42	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	8.07	18.82	0.54	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	12.29	12.61	1.26	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	13.80	14.66	0.43	0.43	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	17.65	17.24	0.82	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	7.84	10.62	1.01	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	14.50	13.23	0.70	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	18.59	16.61	0.40	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	12.02	13.96	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.41	7.22	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	19.86	19.51	2.09	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	14.79	10.50	0.95	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	13.05	13.60	0.55	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	11.70	20.02	0.62	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	9.66	7.79	0.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	14.09	14.27	0.91	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	17.44	18.76	0.99	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	6.44	12.59	0.59	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	7.97	12.94	0.75	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	14.55	13.58	1.94	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	12.93	15.35	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	11.35	19.98	1.06	0.45	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	8.81	12.96	1.56	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	14.66	17.80	1.05	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	10.53	15.64	0.60	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	5.50	17.20	1.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	11.10	12.42	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	9.44	14.21	1.06	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	14.54	17.93	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	10.92	13.23	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	10.78	12.51	0.50	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	18.88	25.54	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	12.60	11.61	0.74	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	11.96	11.00	0.14	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	12.54	16.40	1.61	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	16.13	17.35	1.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	17.50	20.58	1.12	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	12.44	22.76	1.07	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	7.27	8.24	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	6.69	9.96	0.16	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	12.18	17.91	1.07	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	14.05	14.37	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.12	10.36	0.71	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	18.19	21.66	0.50	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	9.48	8.20	0.77	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	13.13	11.93	0.60	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	29.46	6.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	32.99	11.51	2.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	24.49	10.39	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	19.04	7.19	1.69	1.27	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	26.73	7.74	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	24.28	3.74	3.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	20.10	7.73	1.03	1.03	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	35.68	4.76	2.38	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	23.98	7.69	1.36	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	23.85	9.60	1.16	0.87	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	37.36	11.25	2.70	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	24.52	10.57	1.35	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	19.00	9.76	1.54	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	38.11	8.82	2.47	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	35.31	10.66	0.67	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	19.36	7.13	1.53	0.51	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	46.42	11.47	0.27	0.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	35.14	11.90	1.13	0.94	1.13
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	19.63	9.20	1.84	0.00	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	35.06	15.49	1.63	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	33.53	9.16	2.29	0.83	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	31.11	8.41	1.12	0.84	1.96
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	27.82	12.36	3.09	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	39.19	11.32	2.03	1.45	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	28.70	11.96	0.60	0.90	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	35.96	15.49	2.21	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	27.57	11.31	2.12	0.35	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	29.50	9.22	1.11	1.48	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	42.60	13.82	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	25.71	11.90	0.38	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	17.55	9.06	1.13	0.57	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	29.54	9.03	0.82	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	24.85	7.23	2.26	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	30.88	7.18	0.00	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	38.84	10.46	1.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	27.87	10.03	0.37	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	25.41	9.48	1.72	1.72	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	27.40	10.28	0.86	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	24.32	8.33	0.00	1.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	24.13	7.84	1.81	0.00	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	32.71	5.69	0.71	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	27.50	12.03	2.06	0.69	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	24.15	6.98	0.00	0.54	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	29.63	10.77	1.35	0.67	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	30.37	12.22	1.11	1.48	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	27.91	13.96	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	22.21	11.64	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	38.01	13.20	2.40	0.80	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	16.72	5.81	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	45.99	8.43	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	27.13	7.89	1.48	0.99	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	14.11	8.47	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	39.22	5.53	1.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	28.39	9.91	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	10.33	3.44	1.72	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	35.18	10.24	1.34	0.89	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	28.94	12.12	1.17	0.78	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	27.71	6.60	1.32	0.00	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	29.58	12.45	0.52	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	25.82	8.31	1.31	1.31	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	30.75	10.06	1.68	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	27.82	13.69	3.53	1.32	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	30.09	11.96	1.54	1.16	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	24.31	7.60	2.53	0.00	2.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	32.68	16.34	0.96	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	27.43	10.73	0.80	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	25.52	10.94	1.82	1.22	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	20.75	13.83	1.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	32.30	12.92	0.76	1.14	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	21.17	12.39	1.55	1.55	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	20.56	13.30	0.60	1.21	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	37.08	16.48	0.95	0.32	1.90
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	17.59	14.39	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	16.67	12.07	1.72	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	26.23	14.40	1.03	1.03	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	28.29	12.03	1.41	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	16.46	15.32	0.57	1.13	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	27.46	16.64	0.42	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	25.84	10.18	0.00	0.78	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	22.13	13.78	1.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	27.41	18.12	2.79	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	14.72	6.02	0.00	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	27.27	19.25	1.60	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	35.16	19.40	1.21	0.81	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	21.11	6.42	0.00	0.92	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	26.67	17.78	1.78	0.89	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	34.19	18.81	3.42	0.57	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	20.71	13.04	0.77	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	20.79	17.51	2.19	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	40.09	17.82	1.34	0.89	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	27.56	15.60	1.04	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	21.22	16.58	0.66	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	41.57	8.31	6.24	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	46.04	47.41	1.14	0.00	1.14
Macrophage - monocyte derived, donor2	11313-117C8	61.47	34.87	0.37	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	59.25	57.68	1.97	0.92	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	51.51	47.26	1.59	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	61.48	56.41	2.22	0.95	0.00
Mallassez-derived cells, donor3	11930-125I4	66.30	42.39	3.34	0.69	0.42
Mammary Epithelial Cell, donor1	11273-116H4	35.67	38.46	1.99	0.10	0.00
Mammary Epithelial Cell, donor2	11350-117G9	35.90	28.09	2.32	0.29	0.29
Mammary Epithelial Cell, donor3	11422-118F9	26.94	12.47	0.75	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	20.34	33.90	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	28.66	10.06	0.22	0.11	0.00
Mast cell, donor2	11565-120D8	24.37	17.83	0.89	0.30	0.00
Mast cell, donor3	11566-120D9	30.62	12.61	1.58	0.23	0.00
Mast cell, donor4	11567-120E1	32.98	13.12	1.77	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	22.73	6.54	0.33	0.22	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	19.26	16.34	0.58	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	20.76	8.72	0.23	0.34	0.23
Mast cell, expanded, donor8	11941-126A6	26.78	15.57	1.34	0.50	0.00
Melanocyte - dark, donor1	11502-119F8	15.22	32.14	0.90	0.10	0.00
Melanocyte - dark, donor2	11582-120F7	15.57	23.88	2.08	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	39.41	19.12	0.87	0.07	0.14
Melanocyte - light, donor1	11274-116H5	14.10	13.63	0.94	0.00	0.00
Melanocyte - light, donor2	11351-117H1	13.65	8.87	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	19.95	5.20	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	36.44	22.80	1.15	0.83	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	27.43	8.07	1.08	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	32.41	21.96	1.34	0.00	0.00
Meningeal Cells, donor1	11493-119E8	35.36	13.27	3.72	0.00	0.00
Meningeal Cells, donor2	11573-120E7	32.57	8.80	3.96	0.00	0.00
Meningeal Cells, donor3	11654-122E7	31.54	14.51	2.69	0.24	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	27.95	17.96	1.14	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	50.11	52.53	1.61	0.40	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	6.57	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	11.77	3.92	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	38.75	16.50	2.15	0.72	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	58.02	90.64	3.18	0.42	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	41.22	57.80	3.02	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	27.69	13.19	2.42	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	29.22	8.77	2.92	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	25.98	14.53	2.25	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	24.38	43.91	3.32	0.14	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	9.66	12.27	1.12	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	28.16	48.55	2.37	0.00	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	12.17	14.24	1.19	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	7.01	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	20.49	11.53	0.64	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	25.17	21.27	1.77	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	27.83	44.72	2.19	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	41.36	14.51	2.90	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	65.50	44.55	2.92	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	72.07	67.06	6.01	0.50	1.00
Mesothelial Cells, donor3	11402-118D7	49.65	48.85	2.31	1.30	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	72.92	10.80	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	44.08	43.59	1.72	0.49	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	56.83	33.27	1.18	0.29	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	44.94	27.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	38.74	39.36	1.24	0.62	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	42.94	26.14	1.24	0.41	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	27.79	16.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	45.30	43.30	0.75	1.75	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	58.18	28.86	0.47	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	43.89	35.16	0.61	0.41	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	39.20	27.72	1.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	59.86	51.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	17.70	30.97	2.65	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	40.65	34.19	1.14	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	46.06	21.05	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	24.83	43.51	0.85	0.21	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	29.47	14.73	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	31.30	36.06	1.19	0.60	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	43.59	36.89	5.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	33.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	23.58	52.19	1.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	37.31	32.32	0.71	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	27.09	31.51	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	30.62	51.58	1.15	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	48.80	35.76	1.89	0.63	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	39.75	49.33	1.43	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	32.82	46.77	0.64	1.07	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	41.79	32.90	2.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	51.59	30.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	31.98	55.85	0.88	0.66	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	40.56	18.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	39.77	44.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	41.04	64.69	0.54	0.82	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	41.47	36.17	1.47	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	32.71	27.26	2.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	24.99	44.69	0.48	0.48	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	42.02	31.22	1.20	0.80	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	52.11	47.99	6.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	34.54	53.06	1.00	2.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	107.79	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	30.58	55.04	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	44.67	71.38	0.88	1.31	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	43.04	39.73	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	48.67	44.83	3.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	45.12	79.83	1.49	0.74	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	47.32	23.66	2.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	48.62	48.62	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	40.68	73.50	3.08	0.34	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	41.57	28.88	2.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	34.44	48.29	2.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	44.33	66.49	0.84	1.68	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	42.81	31.59	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	35.55	31.47	2.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	44.95	47.06	1.81	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	37.98	33.39	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	57.75	43.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	48.95	55.41	1.85	1.85	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	39.27	34.72	2.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	35.79	29.16	1.24	0.55	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	42.24	47.17	2.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	48.47	40.32	2.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	41.92	20.96	1.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	41.10	43.77	1.33	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	57.77	70.34	3.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	33.76	32.77	1.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	36.31	50.96	1.91	0.64	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	50.86	32.06	2.87	0.66	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	45.88	29.58	1.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	45.17	54.26	0.85	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	50.88	40.56	2.46	0.74	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	44.97	36.49	1.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	53.22	51.45	2.06	1.76	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	55.36	50.46	1.73	0.58	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	71.71	57.29	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	61.94	62.53	1.49	0.60	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	22.60	64.04	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	28.52	40.99	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	42.71	65.39	1.31	1.97	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	29.45	42.08	1.05	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	31.04	54.76	1.19	0.00	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	35.39	56.81	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	36.80	58.21	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	32.49	37.29	0.53	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	34.38	34.27	0.79	0.57	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	20.63	38.31	0.00	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	36.64	55.33	1.10	1.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	35.78	52.89	0.00	1.56	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	41.15	39.01	1.60	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	27.05	42.50	0.00	3.86	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	35.35	42.42	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	37.10	40.48	0.42	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	40.86	38.13	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	20.35	35.60	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	39.68	67.22	1.62	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	30.21	19.64	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	39.97	97.07	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	58.72	65.25	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	38.02	33.27	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	25.10	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	62.69	103.62	6.25	0.43	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	35.02	62.71	8.36	1.05	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	17.35	29.37	4.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	31.30	40.48	3.34	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	51.53	29.09	7.80	0.57	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	35.11	20.75	9.58	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	16.32	37.40	6.80	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	82.69	12.86	7.35	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	20.09	19.67	4.19	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	36.96	50.44	7.44	0.46	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	21.89	33.78	2.97	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	25.65	20.39	3.15	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	66.81	0.00	33.40	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	20.35	41.20	4.47	0.00	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	23.55	14.62	0.81	0.81	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	20.17	37.63	4.53	0.91	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	26.94	30.05	3.59	0.33	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	22.60	27.89	2.37	0.55	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	24.93	33.42	9.55	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	19.21	40.22	7.20	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	37.08	23.63	3.94	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	24.88	42.61	5.69	0.33	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	26.99	31.04	3.17	0.18	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	13.36	39.38	7.03	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	14.25	39.08	4.60	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	25.06	46.59	2.25	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	60.70	25.87	7.93	3.10	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	128.95	22.76	5.06	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	34.09	33.19	4.46	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	27.52	40.22	3.39	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	21.84	38.69	7.12	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	24.90	45.50	4.29	1.72	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	18.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	27.66	36.65	2.00	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	33.36	33.36	5.41	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	20.63	35.32	5.56	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.00	51.08	4.64	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	22.70	36.32	3.03	1.14	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	33.57	50.84	5.87	0.98	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	23.10	30.07	2.18	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	39.80	38.90	4.52	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	17.64	45.86	7.94	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	14.63	46.54	1.99	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	23.81	52.58	1.98	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	21.44	40.58	3.45	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	34.18	36.29	3.93	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	33.37	38.90	3.09	0.88	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	25.07	42.01	4.07	0.68	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	97.08	20.44	5.11	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	14.02	31.70	3.05	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	25.81	34.62	3.15	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	23.30	24.21	3.03	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	20.57	77.53	2.37	2.37	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	68.02	19.27	7.94	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	80.93	35.41	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	39.26	32.30	3.35	0.75	0.12
Myoblast, donor2	11322-117D8	33.75	29.54	3.07	1.53	0.58
Myoblast, donor3	11398-118D3	35.99	28.08	3.03	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	25.39	3.65	1.17	0.29	0.15
Natural Killer Cells, donor1	11230-116C6	17.53	15.68	1.54	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	22.62	20.81	1.21	0.00	0.90
Natural Killer Cells, donor3	11387-118C1	20.80	14.54	0.00	0.37	0.00
Neural stem cells, donor1	11275-116H6	42.10	42.46	1.45	0.36	0.73
Neural stem cells, donor2	11352-117H2	42.36	17.33	7.70	0.00	0.00
Neurons, donor1	11494-119E9	44.38	35.27	5.69	0.00	0.00
Neurons, donor2	11574-120E8	42.93	11.23	6.16	0.22	0.22
Neurons, donor3	11655-122E8	25.49	32.06	4.93	0.00	0.82
Neutrophils, donor1	11233-116C9	51.04	118.78	0.93	0.00	2.78
Neutrophils, donor2	11314-117C9	63.78	110.16	0.00	2.90	0.00
Neutrophils, donor3	11390-118C4	73.91	156.99	6.11	0.61	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	22.80	31.35	1.54	0.00	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	18.23	39.40	2.93	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	25.27	30.89	2.21	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	26.84	91.95	3.03	0.83	0.28
Olfactory epithelial cells, donor2	11934-125I8	25.91	55.29	3.47	2.75	2.17
Olfactory epithelial cells, donor3	11935-125I9	27.70	50.17	3.41	0.23	0.34
Olfactory epithelial cells, donor4	11936-126A1	41.88	68.37	4.87	0.49	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	43.93	25.28	1.81	1.81	0.00
Osteoblast - differentiated, donor1	11276-116H7	25.74	31.69	1.28	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	40.01	20.58	2.29	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	13.03	29.79	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	15.63	22.87	1.37	0.39	0.00
Osteoblast, donor2	11354-117H4	49.86	57.59	1.40	0.00	0.70
Osteoblast, donor3	11426-118G4	38.92	41.94	2.13	0.18	0.00
Pancreatic stromal cells, donor1	11249-116E7	30.24	46.41	2.36	0.25	0.17
Pericytes, donor1	11491-119E6	16.24	4.78	2.11	0.11	0.00
Pericytes, donor2	11571-120E5	23.99	6.56	2.26	0.00	0.23
Pericytes, donor3	11652-122E5	34.18	21.77	2.24	0.81	0.00
Perineurial Cells, donor1	11499-119F5	37.98	16.61	3.73	0.00	0.23
Perineurial Cells, donor2	11579-120F4	26.13	26.96	1.84	0.00	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	29.32	19.76	1.27	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	17.14	20.32	1.22	0.24	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	24.59	19.80	1.29	0.39	0.13
Placental Epithelial Cells, donor1	11278-116H9	24.16	26.31	1.43	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	21.07	4.44	2.22	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	21.99	10.41	0.98	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	43.67	59.81	6.01	1.58	1.27
Preadipocyte - breast, donor1	11467-119B9	34.33	64.15	3.00	0.19	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	47.90	86.54	3.92	0.00	0.39
Preadipocyte - breast, donor2	11328-117E5	56.74	75.42	4.05	2.48	1.58
Preadipocyte - omental, donor1	11468-119C1	38.89	58.71	3.84	0.85	0.11
Preadipocyte - omental, donor2	11329-117E6	75.95	129.20	2.18	0.44	0.87
Preadipocyte - omental, donor3	11403-118D8	88.81	94.97	8.74	0.57	0.86
Preadipocyte - perirenal, donor1	11469-119C2	27.56	50.20	2.95	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	17.51	21.19	1.84	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	53.30	36.30	4.43	1.59	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	52.79	43.59	1.53	1.02	0.51
Preadipocyte - visceral, donor1	11280-116I2	37.26	30.55	2.98	0.19	0.00
Preadipocyte - visceral, donor2	11357-117H7	40.96	26.23	3.68	1.38	0.46
Preadipocyte - visceral, donor3	11429-118G7	34.27	33.44	2.19	1.25	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	27.61	36.66	1.21	0.60	0.75
Prostate Epithelial Cells, donor2	11331-117E8	52.54	21.94	3.79	0.54	0.81
Prostate Epithelial Cells, donor3	11404-118D9	25.17	7.23	3.12	0.18	0.18
Prostate Stromal Cells, donor1	11254-116F3	31.78	50.46	2.96	0.34	0.23
Prostate Stromal Cells, donor2	11332-117E9	34.96	27.43	1.43	0.18	0.54
Prostate Stromal Cells, donor3	11405-118E1	37.64	45.15	3.13	0.94	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	28.10	5.47	3.65	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	39.99	12.55	2.98	0.42	0.21
Renal Epithelial Cells, donor1	11517-119H5	19.78	7.10	1.01	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	22.05	9.96	3.56	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	38.53	11.54	3.18	0.21	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	14.98	6.81	1.36	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	15.90	7.41	1.89	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	34.41	20.20	2.89	0.44	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	8.65	2.66	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	34.77	15.85	1.32	0.22	0.22
Renal Mesangial Cells, donor2	11598-120H5	23.20	23.83	5.64	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	21.08	12.48	2.50	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	48.58	18.79	6.44	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	32.89	14.34	2.53	0.84	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	37.22	9.45	2.31	0.39	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	21.26	3.11	1.56	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	35.53	6.82	2.27	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	18.52	3.09	3.09	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	19.07	5.02	1.76	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	35.01	43.03	3.07	0.13	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	16.08	22.34	1.79	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	10.46	23.67	0.55	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	12.18	18.56	0.58	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	16.38	12.22	1.30	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	19.66	9.43	2.68	0.30	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	21.97	12.27	1.45	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	23.57	15.38	1.49	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	19.00	9.32	1.86	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	23.34	12.71	2.31	0.92	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	19.85	12.73	2.46	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	18.15	12.10	1.06	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	20.25	11.11	1.08	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	19.51	13.63	3.01	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	17.71	11.48	2.25	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	24.56	12.61	1.77	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	23.32	12.04	2.10	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	23.20	10.15	1.96	0.09	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	19.54	11.65	2.44	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	23.09	13.67	2.26	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	21.32	9.93	2.24	0.39	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	21.58	12.22	1.72	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	20.82	15.59	3.10	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	17.66	7.57	1.96	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	19.31	11.96	1.54	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	23.16	14.22	1.46	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	19.87	7.97	0.86	0.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	25.79	11.15	2.01	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	19.11	15.33	2.83	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	17.06	8.73	1.79	0.40	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	22.92	11.69	1.40	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	16.17	16.17	1.66	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	22.56	9.95	2.21	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	19.22	10.44	1.25	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	21.26	15.88	2.29	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	25.88	10.73	2.04	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	21.40	14.07	0.96	0.39	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	21.66	16.68	2.24	0.69	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	22.91	11.11	3.29	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	24.46	9.85	0.66	0.99	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	19.43	15.34	1.70	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	21.16	9.47	1.63	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	19.46	14.39	1.07	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	20.33	11.34	2.49	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	23.33	8.81	1.90	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	34.06	13.91	3.83	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	18.65	16.67	1.22	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	17.47	17.82	2.10	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	20.25	16.02	1.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	23.62	21.30	1.96	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	28.53	32.60	1.75	0.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	21.29	29.20	1.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	18.39	23.81	1.81	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	30.76	26.69	2.04	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	29.06	26.66	1.20	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	20.31	28.81	1.89	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	25.83	21.98	0.85	0.21	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	20.43	26.44	0.60	0.00	0.00
Schwann Cells, donor1	11498-119F4	24.64	6.39	3.20	0.00	0.00
Schwann Cells, donor2	11578-120F3	40.83	10.21	10.21	0.00	0.00
Schwann Cells, donor3	11659-122F3	31.33	16.21	3.51	0.66	0.44
Sebocyte, donor1	11220-116B5	38.34	19.72	2.74	0.00	0.00
Sebocyte, donor2	11301-117B5	37.68	14.71	3.22	0.00	0.92
Sebocyte, donor3	11378-118B1	28.44	13.81	1.24	0.82	0.21
Sertoli Cells, donor1	11255-116F4	51.35	66.26	3.31	0.00	0.00
Sertoli Cells, donor2	11333-117F1	53.66	56.49	8.47	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	21.91	19.71	1.76	0.18	0.09
Skeletal Muscle Cells, donor2	11358-117H8	10.12	2.89	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	28.43	15.88	1.67	0.84	1.67
Skeletal Muscle Cells, donor4	11451-119A2	25.29	8.80	2.67	0.31	0.00
Skeletal Muscle Cells, donor5	11455-119A6	19.62	8.62	1.93	0.45	0.15
Skeletal Muscle Cells, donor6	11459-119B1	25.70	8.46	1.85	0.46	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	25.08	17.89	2.27	0.13	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	25.11	12.84	1.85	0.29	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	33.04	10.12	1.98	0.40	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	23.59	21.06	1.52	0.00	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	14.48	10.13	0.72	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	15.55	15.27	0.96	0.41	0.14
Skin - palm, donor1	10286-104F7	21.49	77.90	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	23.50	16.43	1.59	0.29	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	20.45	37.62	3.27	0.82	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	22.46	16.88	2.86	0.39	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	28.36	16.26	1.95	0.56	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	29.40	16.18	1.13	0.14	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	65.55	49.06	3.17	0.42	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	37.48	9.52	3.00	0.07	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	8.02	3.09	1.85	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	110.50	83.82	11.34	1.33	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	41.15	25.86	2.35	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	31.38	37.13	0.66	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	31.11	25.60	0.79	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	41.72	22.40	2.32	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	11.01	19.01	2.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	48.97	46.18	1.73	0.00	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	83.79	69.60	6.65	1.33	1.77
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	52.62	48.52	4.74	0.51	0.77
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	25.40	13.35	1.63	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	42.23	35.14	2.95	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	42.14	30.04	3.56	0.71	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	17.08	7.48	1.63	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	24.96	19.79	2.44	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	22.98	13.89	0.76	0.00	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	12.24	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	24.32	32.90	2.38	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	20.20	24.04	1.92	0.15	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	20.45	25.83	1.29	0.86	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	30.33	22.04	1.89	0.31	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	31.55	26.60	2.78	0.31	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	30.18	9.70	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	30.18	26.90	1.20	0.30	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	22.87	6.83	0.68	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	19.55	19.63	1.49	0.00	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	56.76	41.67	6.24	0.20	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	99.67	111.96	5.01	2.73	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	22.94	25.96	1.81	2.42	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	40.53	15.10	3.44	0.00	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	32.22	48.34	2.80	0.00	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	39.44	38.57	4.76	0.63	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	25.37	37.54	3.80	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	39.50	56.69	1.81	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	24.01	19.50	1.50	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	102.08	98.21	7.75	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	36.74	29.76	1.40	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	57.56	36.86	4.54	0.00	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	53.59	41.68	3.76	0.00	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	16.22	6.49	0.88	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	43.07	21.41	3.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	21.96	21.49	0.93	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	38.57	33.53	2.45	0.14	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	38.75	37.99	1.53	0.25	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	17.49	18.43	0.75	0.00	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	33.68	21.24	1.40	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	45.41	30.75	1.34	0.08	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	5.71	1.43	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	41.59	32.78	3.18	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	34.91	98.76	3.98	0.44	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	24.28	35.11	0.59	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	18.46	28.96	2.33	0.39	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	18.51	23.54	2.64	0.79	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	17.11	37.94	0.74	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	33.42	41.32	2.52	2.16	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	34.64	31.23	5.39	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	22.06	42.14	3.94	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	14.98	26.41	0.76	0.76	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	22.36	28.35	2.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	15.47	22.57	0.00	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	16.04	27.04	0.46	0.46	0.00
Synoviocyte, donor1	11291-117A4	65.14	187.00	6.73	0.84	0.84
Synoviocyte, donor2	11368-117I9	37.21	61.69	1.68	0.50	0.00
Synoviocyte, donor3	11440-118H9	30.38	59.87	2.68	1.12	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	27.87	5.72	3.93	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	3.96	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	10.65	3.01	1.62	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	24.59	9.39	2.51	0.22	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	28.22	11.60	1.16	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	10.31	7.44	2.29	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	28.54	39.74	3.32	0.00	0.00
Urethra, donor2	10319-105A4	39.57	165.46	8.99	0.00	1.80
Urothelial Cells, donor1	11520-119H8	37.46	8.24	1.59	0.27	0.27
Urothelial Cells, donor2	11600-120H7	32.05	5.61	2.40	0.80	0.40
Urothelial Cells, donor3	11681-122H7	37.13	3.90	1.60	0.23	0.00
Urothelial cells, donor0	11216-116B1	49.93	13.82	1.56	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	107.66	102.33	3.56	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	94.35	101.50	4.29	1.43	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	67.77	56.13	2.74	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	44.76	51.31	1.72	0.69	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	44.16	39.51	1.16	0.58	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	66.64	90.59	4.16	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	73.42	86.27	1.84	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	64.82	72.12	0.91	3.65	0.91
Wilms' tumor cell line:G-401	10809-111A8	32.57	6.41	2.96	0.12	0.00
Wilms' tumor cell line:HFWT	10597-108E3	57.20	9.68	6.16	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	18.43	5.31	1.40	0.56	0.00
achilles tendon, donor2	10292-104G4	16.53	39.26	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	13.77	8.16	1.02	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	19.04	1.63	0.00	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	25.17	4.87	0.95	0.12	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	25.58	1.63	2.45	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	16.30	3.65	1.12	0.56	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	24.11	7.61	0.85	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	26.40	14.97	1.91	0.27	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	29.52	6.17	1.76	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	16.74	1.23	0.41	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	25.24	5.05	1.16	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	27.60	4.60	2.02	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	31.20	15.60	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	16.96	5.81	0.23	0.23	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	19.16	3.88	1.81	0.26	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	26.01	4.09	0.58	0.29	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	26.49	17.66	3.72	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	30.43	10.69	0.41	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	39.29	7.37	2.15	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	35.84	8.11	0.43	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	34.27	4.25	0.91	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	41.16	2.65	2.17	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	33.63	11.81	5.35	1.11	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	21.35	6.67	0.67	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	7.43	7.43	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	22.98	12.43	2.64	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	20.50	1.74	1.31	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	11.25	3.75	5.62	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	36.50	7.06	1.41	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	22.18	26.99	0.93	0.47	0.16
adipose, donor1	10184-103D4	22.87	22.28	1.76	1.76	1.17
adipose, donor2	10185-103D5	18.65	12.17	4.06	0.00	0.00
adipose, donor3	10186-103D6	36.76	21.78	3.00	0.54	0.54
adipose, donor4	10187-103D7	52.87	12.13	4.33	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	75.44	0.79	12.94	0.16	0.00
adrenal gland, adult, pool1	10081-102A9	10.91	21.83	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	18.94	3.34	1.07	0.00	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	24.65	10.00	1.43	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	69.32	222.11	5.10	0.70	0.00
amniotic membrane cells, donor2	12236-129G4	57.82	75.06	3.72	0.00	0.34
amniotic membrane cells, donor3	12237-129G5	63.63	213.29	9.72	0.29	0.00
amygdala - adult, donor10196	10167-103B5	161.27	30.83	56.92	1.19	3.56
amygdala, adult, donor10252	10151-102I7	235.62	35.89	43.19	0.81	0.81
amygdala, newborn, donor10223	10360-105E9	85.86	35.83	34.86	0.65	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	48.51	78.82	2.29	0.38	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	29.56	8.38	0.88	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	37.75	4.34	1.34	0.33	0.00
aorta, adult, pool1	10052-101G7	57.86	138.08	2.75	0.78	0.78
appendix, adult	10189-103D9	39.98	59.77	2.33	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	35.08	15.13	3.10	0.00	0.00
artery, adult	10190-103E1	27.17	42.12	2.72	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	86.20	49.54	2.75	0.00	0.29
b cell line:RPMI1788	10427-106D4	17.84	4.61	1.04	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	129.85	206.70	7.77	0.55	1.66
bile duct carcinoma cell line:HuCCT1	10432-106D9	37.81	11.21	3.67	0.10	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	74.48	7.03	2.18	0.67	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	12.86	1.12	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	33.90	111.36	2.93	0.98	0.65
blood, adult, pool1	10053-101G8	73.08	42.08	2.21	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	48.81	47.96	0.86	0.00	0.00
bone marrow, adult	10192-103E3	42.51	58.71	2.02	0.67	2.02
brain, adult, donor1	10084-102B3	150.69	36.90	15.38	1.03	1.03
brain, adult, pool1	10012-101C3	175.28	28.28	12.58	1.34	0.45
brain, fetal, pool1	10085-102B4	82.81	21.37	16.03	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	37.00	20.81	0.99	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	16.98	13.11	1.50	0.00	0.00
breast, adult, donor1	10080-102A8	27.15	50.51	5.68	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	75.46	13.59	5.46	0.51	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	115.65	53.50	7.73	0.00	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	30.16	21.18	11.05	0.46	1.15
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	40.19	9.68	2.42	0.24	0.48
carcinoid cell line:NCI-H1770	10703-109H1	31.03	0.47	0.94	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	85.10	37.85	3.83	0.55	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	22.82	8.56	3.80	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	38.86	26.09	2.66	0.53	0.27
caudate nucleus - adult, donor10196	10177-103C6	176.15	33.39	43.75	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	240.28	20.41	27.27	1.67	1.17
caudate nucleus, adult, donor10258	10379-105H1	235.35	20.63	36.68	1.53	0.76
caudate nucleus, newborn, donor10223	10354-105E3	91.19	22.71	28.93	0.73	1.46
cerebellum - adult, donor10196	10173-103C2	107.79	90.31	34.96	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	196.86	57.86	34.80	0.85	1.07
cerebellum, adult, pool1	10083-102B2	115.90	71.40	12.76	2.41	1.03
cerebellum, newborn, donor10223	10357-105E6	39.02	100.46	19.10	0.00	0.83
cerebral meninges, adult	10188-103D8	168.68	44.12	21.68	1.01	0.00
cerebrospinal fluid, donor2	10294-104G6	48.97	9.50	13.16	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	17.69	12.08	1.15	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	63.47	99.76	2.98	0.17	0.00
cervix, adult, pool1	10013-101C4	50.29	113.91	3.57	0.84	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	74.82	14.07	8.92	0.28	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	31.35	26.13	10.45	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	40.27	8.82	1.62	0.12	0.37
choriocarcinoma cell line:SCH	10785-110H2	65.92	2.71	1.97	0.62	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	91.55	7.83	9.72	0.47	0.00
chorionic membrane cells, donor1	12238-129G6	52.43	133.34	1.99	0.00	0.85
chorionic membrane cells, donor2	12239-129G7	49.82	62.24	2.39	0.50	0.40
chorionic membrane cells, donor3	12240-129G8	54.40	98.91	2.20	0.55	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	8.08	3.03	2.02	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	22.48	5.38	0.77	0.19	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	13.30	5.07	0.63	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	8.47	3.08	0.77	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	8.71	2.42	1.45	0.00	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	8.96	3.05	1.02	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	5.59	1.77	0.59	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	13.81	4.43	0.78	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	37.72	3.66	5.49	1.37	0.91
clear cell carcinoma cell line:TEN	10636-108I6	114.17	95.43	4.51	1.74	1.21
colon carcinoma cell line:CACO-2	10513-107D9	47.41	38.26	2.38	0.37	0.18
colon carcinoma cell line:COLO-320	10420-106C6	10.64	6.08	0.38	0.00	0.38
colon, adult, donor1	10082-102B1	35.70	128.52	9.52	0.00	0.00
colon, adult, pool1	10014-101C5	51.47	120.91	1.41	0.35	0.35
colon, fetal, donor1	10070-101I7	42.02	117.42	4.94	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	82.50	9.17	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	26.35	17.42	1.27	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	20.38	5.89	0.00	0.30	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	24.39	4.09	0.71	0.42	0.00
corpus callosum, adult, pool1	10042-101F6	54.06	22.78	6.63	0.33	0.22
cruciate ligament, donor2	10295-104G7	29.18	74.56	4.86	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	28.89	40.13	0.80	0.00	0.00
diencephalon, adult	10193-103E4	155.03	27.84	23.52	0.48	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	17.22	3.67	0.46	0.46	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	34.62	15.90	1.80	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	15.41	5.78	1.69	0.00	0.24
ductus deferens, adult	10196-103E7	49.34	91.20	6.48	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	38.89	120.98	5.76	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	50.76	119.91	3.68	2.94	1.47
dura mater, adult, donor1	10041-101F5	37.33	48.73	2.40	0.33	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	19.99	30.20	3.33	0.67	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	44.13	30.38	8.17	0.29	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	37.61	2.47	2.47	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	32.09	2.72	1.82	1.51	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	40.75	5.87	1.54	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	43.34	6.57	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	9.05	10.73	0.67	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	48.39	18.12	1.09	0.36	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	50.01	25.41	3.06	0.96	1.13
epidermoid carcinoma cell line:A431	10426-106D3	76.14	28.12	7.89	0.00	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	47.62	11.77	3.08	0.00	0.11
epididymis, adult	10197-103E8	47.93	64.89	2.72	1.05	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	44.53	35.48	3.90	0.35	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	33.43	2.75	3.15	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	46.52	16.25	3.67	0.79	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	44.39	12.20	3.54	0.30	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	52.09	15.01	3.81	1.34	0.45
esophagus, adult, pool1	10015-101C6	37.27	74.75	2.55	0.64	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	57.61	2.88	2.76	0.00	0.13
eye - muscle inferior rectus, donor1	10272-104E2	45.88	36.22	4.83	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	12.63	21.04	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	26.79	46.13	4.46	1.49	0.00
eye - muscle superior, donor2	10297-104G9	32.10	44.71	2.29	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	24.78	26.23	5.83	0.00	0.00
eye, fetal, donor1	10054-101G9	55.42	64.07	2.29	1.02	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	44.37	30.90	1.92	0.13	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	39.65	9.26	7.12	0.00	0.24
frontal lobe, adult, pool1	10040-101F4	249.76	45.32	19.98	0.56	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	47.14	13.51	5.40	0.30	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	46.36	4.66	2.29	0.09	0.09
gall bladder, adult	10198-103E9	48.77	97.30	2.90	0.97	0.48
gamma delta positive T cells, donor1	11937-126A2	21.47	4.83	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	29.13	20.54	0.75	0.00	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	26.40	37.17	2.96	0.84	1.48
gastric adenocarcinoma cell line:MKN45	10612-108F9	65.76	11.02	2.90	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	30.33	4.59	3.28	0.00	0.16
gastric cancer cell line:GSS	10560-108A2	25.63	1.83	4.58	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	59.63	45.23	2.28	0.46	0.23
giant cell carcinoma cell line:LU65	10487-107B1	20.54	7.34	0.57	0.11	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	38.91	14.42	2.24	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	64.60	10.48	5.24	0.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	14.04	7.07	1.37	0.00	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	19.66	5.62	0.98	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	31.46	19.43	1.99	0.22	0.33
glioma cell line:GI-1	10413-106B8	33.68	13.18	1.17	0.59	0.29
globus pallidus - adult, donor10196	10175-103C4	81.64	22.60	30.61	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	88.85	25.63	13.18	1.22	0.49
globus pallidus, adult, donor10258	10367-105F7	58.88	15.06	13.69	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	60.22	23.98	19.72	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	122.36	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	38.40	36.48	0.32	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	31.68	20.20	12.86	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	27.44	15.55	7.77	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	19.32	18.68	8.37	0.00	0.00
hIPS, biol_rep1	14380-156B6	28.75	18.68	10.06	0.00	1.44
hIPS, biol_rep2	14381-156B7	22.63	10.29	6.86	0.00	0.00
hIPS, biol_rep3	14382-156B8	97.11	25.38	32.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	22.70	2.87	1.72	0.29	0.00
heart - mitral valve, adult	10205-103F7	56.80	105.54	5.68	0.00	0.90
heart - pulmonic valve, adult	10206-103F8	57.00	82.63	3.66	0.26	0.00
heart - tricuspid valve, adult	10207-103F9	54.95	51.62	9.16	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	59.38	38.16	4.08	0.20	0.61
heart, adult, diseased, donor1	10051-101G6	63.87	72.82	4.68	0.85	0.85
heart, adult, pool1	10016-101C7	76.35	70.37	4.83	0.46	0.00
heart, fetal, pool1	10046-101G1	92.51	113.26	7.80	0.21	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	78.67	97.19	8.95	0.62	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	27.35	64.22	8.32	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	50.94	47.29	2.87	0.66	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	53.89	42.60	2.43	1.09	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	56.69	43.25	2.83	1.21	0.51
hepatoma cell line:Li-7	10484-107A7	23.13	42.82	2.00	0.22	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	28.14	3.22	1.91	0.00	0.10
hippocampus - adult, donor10196	10169-103B7	133.43	34.07	37.85	3.79	0.00
hippocampus, adult, donor10252	10153-102I9	149.81	30.00	27.76	1.02	0.82
hippocampus, adult, donor10258	10374-105G5	111.54	24.40	18.42	1.99	1.49
hippocampus, newborn, donor10223	10363-105F3	99.75	18.68	26.08	1.06	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	32.35	15.26	12.82	1.83	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	43.20	11.98	10.41	0.39	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	35.04	13.71	8.63	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	34.96	14.10	6.77	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	33.57	15.49	6.20	0.77	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	18.60	14.80	5.31	1.14	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	14.60	18.98	3.50	1.17	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	27.79	20.47	3.66	1.29	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	19.60	22.94	4.59	1.25	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	21.07	21.55	2.84	0.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	23.46	19.13	2.09	0.80	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	19.53	24.91	3.37	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	52.58	13.61	15.34	0.63	1.41
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	43.73	19.16	11.30	1.97	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	22.69	13.96	14.84	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	39.90	23.29	6.49	1.53	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	32.27	20.50	6.98	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	14.49	20.49	4.50	1.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	16.01	10.17	1.51	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	18.64	16.82	1.82	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	11.90	15.66	1.25	0.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	28.25	33.48	2.78	0.82	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	27.58	33.97	3.77	1.74	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	23.02	21.82	4.18	1.49	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	51.91	19.58	10.90	0.74	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	40.80	17.12	11.98	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	37.16	19.19	11.84	1.63	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	32.74	22.18	2.82	1.06	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	33.26	21.22	6.02	1.27	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	29.35	16.04	6.66	0.61	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	18.10	14.48	4.14	1.55	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	12.62	13.95	2.66	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	13.85	12.06	3.08	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	30.42	30.68	3.32	2.56	1.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	27.26	21.96	3.79	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	28.56	24.53	5.04	0.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	42.26	14.97	12.08	0.97	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	33.87	21.39	7.58	2.23	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	32.68	17.07	8.29	0.49	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	28.73	17.73	4.28	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	29.28	42.29	3.25	6.51	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	18.53	19.19	4.63	0.33	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	20.25	22.44	8.21	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	13.39	19.18	4.70	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	16.01	25.27	4.27	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	21.48	25.06	4.77	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	26.54	31.15	3.66	0.27	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	14.28	18.86	3.23	0.00	0.27
immature langerhans cells, donor1	11904-125F5	21.79	55.69	1.21	0.48	0.24
immature langerhans cells, donor2	11905-125F6	32.48	72.88	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	267.62	51.58	27.16	0.76	0.66
keratoacanthoma cell line:HKA-1	10791-110H8	33.17	31.54	1.30	0.33	0.00
kidney, adult, pool1	10017-101C8	52.77	66.89	3.40	1.00	0.10
kidney, fetal, pool1	10045-101F9	56.94	54.89	3.40	0.07	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	40.33	44.88	2.70	0.14	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	19.49	41.89	1.11	0.55	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	31.19	11.19	1.10	0.00	0.00
left atrium, adult, donor1	10079-102A7	49.58	66.47	5.99	1.09	0.00
left ventricle, adult, donor1	10078-102A6	40.96	49.55	3.54	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	39.13	5.20	6.57	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	39.52	27.66	4.67	2.51	0.72
leiomyoma cell line:15242A	10570-108B3	54.35	67.39	2.72	1.63	0.54
leiomyoma cell line:15425	10571-108B4	44.19	44.19	2.91	2.19	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	50.79	107.94	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	19.87	25.09	2.09	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	20.66	13.58	2.72	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	34.83	42.02	2.97	0.16	0.16
liposarcoma cell line:SW 872	10726-110A6	46.06	29.00	4.02	0.00	0.24
liver, adult, pool1	10018-101C9	25.44	23.50	0.97	0.00	0.16
liver, fetal, pool1	10086-102B5	15.05	19.75	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	88.08	29.46	41.41	0.73	0.00
locus coeruleus, adult, donor10252	10165-103B3	95.23	23.81	23.62	1.11	1.66
locus coeruleus, adult, donor10258	10375-105G6	53.04	22.29	18.90	2.54	0.00
locus coeruleus, newborn, donor10223	10362-105F2	39.54	38.70	16.40	1.68	0.42
lung adenocarcinoma cell line:A549	10499-107C4	49.27	12.46	4.84	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	30.33	2.07	1.38	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	74.48	30.05	4.35	0.26	0.13
lung, adult, pool1	10019-101D1	40.16	49.73	3.54	0.47	0.47
lung, fetal, donor1	10068-101I5	48.23	125.29	7.99	0.29	0.57
lung, right lower lobe, adult, donor1	10075-102A3	54.99	71.02	4.58	1.37	0.46
lymph node, adult, donor1	10077-102A5	35.03	25.09	1.42	0.95	0.47
lymphangiectasia cell line:DS-1	10727-110A7	23.67	5.26	1.32	0.00	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	56.60	22.94	1.51	0.91	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	65.41	39.08	1.70	0.00	0.00
mature adipocyte, donor1	12231-129F8	33.30	15.10	0.89	0.00	0.00
mature adipocyte, donor2	12232-129F9	33.41	24.28	1.66	0.00	0.00
mature adipocyte, donor3	12233-129G1	30.34	18.97	0.71	0.24	0.24
mature adipocyte, donor4	12234-129G2	24.22	27.64	1.32	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	32.40	13.82	2.86	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	154.54	39.48	37.23	3.38	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	217.01	31.45	24.28	1.84	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	139.78	32.72	27.96	0.95	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	93.83	31.56	20.90	2.99	2.99
medial temporal gyrus - adult, donor10196	10183-103D3	192.38	33.08	40.84	7.59	8.94
medial temporal gyrus, adult, donor10252	10156-103A3	216.04	44.57	23.98	0.42	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	92.46	17.34	25.04	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	215.30	114.83	14.35	28.71	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	114.14	43.07	32.66	0.36	0.36
medulla oblongata - adult, donor10196	10174-103C3	65.55	36.99	18.82	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	88.70	28.64	18.89	0.77	0.31
medulla oblongata, adult, pool1	10038-101F2	82.93	29.30	13.47	0.00	0.00
medulla oblongata, newborn, donor10223	10361-105F1	35.41	22.57	15.62	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	31.00	17.05	5.09	0.89	0.22
medulloblastoma cell line:ONS-76	10759-110E3	38.52	9.90	5.99	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	22.57	10.21	0.86	0.00	0.14
melanoma cell line:G-361	10465-106H6	30.95	14.93	0.81	0.27	0.81
meningioma cell line:HKBMM	10691-109F7	28.22	23.52	0.54	1.45	0.72
merkel cell carcinoma cell line:MKL-1	10843-111E6	53.75	4.41	1.76	0.88	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	35.00	2.59	4.15	1.04	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	38.36	35.14	3.38	0.46	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	20.36	22.36	0.91	0.36	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	28.57	33.96	1.66	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	31.75	39.33	0.98	0.42	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	39.28	46.79	2.50	0.19	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	33.32	43.03	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	35.70	26.43	2.57	0.86	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	39.45	23.46	3.57	0.46	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	36.08	26.13	2.79	0.40	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	52.53	43.21	3.65	0.41	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	51.64	57.05	5.41	0.71	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	38.21	38.86	4.61	0.66	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	58.81	49.26	2.35	0.55	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	50.62	52.36	4.54	1.05	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	59.62	43.90	2.86	0.00	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	45.65	57.51	4.31	1.44	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	46.35	51.10	2.59	0.41	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	51.75	64.29	5.24	1.37	1.37
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	52.44	56.22	2.94	1.68	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	51.56	52.45	2.99	0.60	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	44.29	52.52	2.36	0.53	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	43.44	37.92	0.74	1.84	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	64.67	76.69	3.43	1.43	1.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	34.10	14.31	2.53	1.26	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	32.88	77.18	6.39	1.37	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	27.88	60.37	5.37	0.26	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	36.12	70.94	2.36	1.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	37.89	73.63	4.62	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	36.01	58.60	3.53	1.18	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	38.92	73.78	3.72	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	26.33	67.98	5.50	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	28.73	61.63	2.78	1.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	37.78	76.14	3.75	0.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	36.81	70.95	5.58	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	39.18	69.46	6.01	0.24	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	54.27	88.00	7.33	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	27.86	64.45	5.03	0.34	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	28.25	62.63	3.28	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	39.09	73.88	3.87	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	35.55	68.36	5.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	87.80	5.16	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	34.43	77.30	2.92	1.30	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	24.73	69.84	4.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	20.79	53.84	3.73	0.53	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	30.26	61.33	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	25.66	62.58	3.50	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	20.99	60.86	4.20	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	26.82	55.63	3.97	0.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	52.44	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	26.09	61.67	1.19	1.19	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	24.37	70.67	6.09	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	54.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	24.07	67.14	3.80	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	13.45	37.59	0.69	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	25.79	36.54	4.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	11.98	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	13.78	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	7.33	19.97	0.81	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	15.89	20.66	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	12.38	21.22	1.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	7.48	23.07	1.87	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	12.03	22.72	2.67	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	10.64	21.29	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	41.09	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	19.28	22.03	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	20.78	34.64	1.48	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	7.85	40.37	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	24.17	31.17	1.27	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	14.51	28.61	1.21	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	17.44	37.07	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	13.94	32.94	2.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	12.74	32.17	2.43	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	72.30	9.04	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	19.77	29.65	0.82	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	15.87	51.59	0.40	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	13.30	43.48	0.97	0.97	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	16.30	36.67	2.04	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	34.82	62.67	3.09	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	36.62	10.87	2.36	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	44.02	72.51	2.09	0.23	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	29.92	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	17.98	17.67	0.62	0.10	0.10
mesothelioma cell line:Mero-25	10850-111F4	23.38	16.79	2.27	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	24.45	20.05	1.71	0.00	0.24
mesothelioma cell line:Mero-48a	10852-111F6	11.74	8.41	0.89	0.44	0.00
mesothelioma cell line:Mero-82	10853-111F7	19.97	25.75	2.37	0.53	0.00
mesothelioma cell line:Mero-83	10854-111F8	17.53	9.53	1.36	0.51	0.00
mesothelioma cell line:Mero-84	10855-111F9	39.43	26.79	7.08	1.52	0.76
mesothelioma cell line:Mero-95	10856-111G1	25.26	34.78	1.86	0.62	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	24.18	23.85	1.66	0.33	0.17
mesothelioma cell line:NCI-H226	10846-111E9	30.23	26.97	1.09	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	31.43	24.60	2.05	0.34	0.17
mesothelioma cell line:NCI-H28	10845-111E8	33.84	6.11	6.11	1.27	0.25
mesothelioma cell line:No36	10857-111G2	37.51	32.95	1.63	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	18.15	13.55	0.81	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	20.54	10.36	1.92	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	23.20	9.53	2.56	0.37	0.37
migratory langerhans cells, donor3	11903-125F4	23.51	11.49	1.97	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	21.55	14.69	0.33	0.33	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	28.19	13.78	1.48	0.64	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	34.78	4.38	3.69	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	21.69	2.47	0.76	0.19	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	51.19	10.16	1.66	1.11	0.00
myeloma cell line:PCM6	10474-106I6	18.78	6.72	0.20	0.00	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	33.48	20.29	8.12	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	45.70	14.91	3.14	0.39	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	24.51	4.90	1.56	0.11	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	18.61	4.56	2.79	0.15	0.15
nasal epithelial cells, donor2	12227-129F4	29.81	19.32	3.31	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	29.91	6.21	3.22	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	46.21	30.49	5.99	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	33.53	13.29	1.48	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	47.15	16.96	2.80	0.19	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	41.28	17.55	4.51	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	102.00	55.27	7.92	2.06	0.95
neuroectodermal tumor cell line:TASK1	10774-110F9	28.78	7.65	2.62	0.20	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	38.78	4.45	13.35	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	55.89	72.66	5.59	0.00	0.00
neutrophil PMN, donor1	12133-128D9	238.00	163.62	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	92.96	66.40	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	66.29	56.82	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	30.44	1.18	0.34	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	32.02	24.02	4.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	41.36	62.20	2.56	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	41.52	63.33	1.58	0.26	0.79
nucleus accumbens, adult, pool1	10037-101F1	265.19	29.90	25.31	0.47	0.28
occipital cortex - adult, donor10196	10172-103C1	185.43	39.15	37.09	2.06	2.06
occipital cortex, adult, donor10252	10163-103B1	200.20	38.38	22.54	0.81	0.81
occipital cortex, newborn, donor10223	10355-105E4	134.66	41.85	32.03	1.46	0.36
occipital lobe, adult, donor1	10076-102A4	214.90	47.23	36.21	0.26	3.94
occipital lobe, fetal, donor1	10073-102A1	63.08	33.47	12.44	0.43	0.00
occipital pole, adult, pool1	10036-101E9	243.23	32.80	18.21	0.16	0.08
olfactory region, adult	10195-103E6	178.63	37.06	24.45	0.96	0.96
optic nerve, donor1	10277-104E7	56.03	28.01	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	70.05	21.53	1.71	0.11	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	34.07	4.26	3.71	0.14	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	26.25	15.07	2.20	0.68	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	19.41	10.16	1.27	0.12	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	85.84	118.17	5.88	1.18	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	49.52	15.88	4.67	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	48.77	74.01	2.97	0.21	0.00
ovary, adult, pool1	10020-101D2	27.87	45.16	1.75	0.09	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	24.38	13.57	5.13	0.00	0.00
pancreas, adult, donor1	10049-101G4	33.86	34.80	0.00	0.94	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	51.99	13.42	2.80	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	30.32	19.76	1.53	0.85	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	35.93	12.92	1.82	0.00	0.33
paracentral gyrus, adult, pool1	10035-101E8	254.34	38.71	23.80	0.64	0.55
parietal cortex, adult, donor10258	10373-105G4	148.27	24.22	33.03	1.47	0.73
parietal lobe - adult, donor10196	10171-103B9	132.61	30.10	26.33	2.82	1.88
parietal lobe, adult, donor10252	10157-103A4	255.39	36.77	24.51	0.57	1.43
parietal lobe, adult, pool1	10034-101E7	235.54	36.31	18.95	0.26	0.18
parietal lobe, fetal, donor1	10072-101I9	85.35	18.43	16.49	0.97	0.97
parietal lobe, newborn, donor10223	10356-105E5	102.06	50.47	30.66	2.24	1.87
parotid gland, adult	10199-103F1	33.30	120.25	3.08	1.23	0.00
penis, adult	10200-103F2	36.52	128.91	4.83	0.54	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	37.56	9.30	4.83	0.74	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	57.84	19.38	1.60	0.58	0.29
pineal gland - adult, donor10196	10179-103C8	27.09	11.61	3.23	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	68.10	15.99	8.88	0.59	0.59
pineal gland, adult, donor10258	10377-105G8	29.47	10.66	3.14	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	53.63	55.65	9.11	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	125.60	46.91	8.86	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	58.74	33.20	8.51	0.00	0.00
placenta, adult, pool1	10021-101D3	42.57	38.16	2.58	0.00	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	27.02	18.27	1.99	0.40	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	44.20	57.12	1.40	0.62	0.00
pons, adult, pool1	10033-101E6	150.88	32.88	30.47	0.09	0.09
postcentral gyrus, adult, pool1	10032-101E5	238.34	39.66	21.18	1.05	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	161.04	10.46	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	11.02	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	38.02	10.20	1.31	0.73	0.44
prostate cancer cell line:PC-3	10439-106E7	37.75	31.58	3.27	0.18	0.18
prostate, adult, pool1	10022-101D4	46.16	90.69	4.26	0.36	0.18
putamen, adult, donor10196	10176-103C5	394.23	25.02	40.84	2.12	1.42
putamen, adult, donor10252	10152-102I8	101.96	19.61	13.73	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	101.63	7.65	16.39	0.00	4.37
putamen, adult, donor10258, tech_rep2	10372-105G3	278.58	17.64	37.69	1.69	0.48
putamen, newborn, donor10223	10365-105F5	53.98	32.99	19.49	1.50	0.00
rectal cancer cell line:TT1TKB	10469-106I1	39.57	41.89	1.16	0.00	0.00
rectum, fetal, donor1	10067-101I4	37.56	158.57	4.17	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	48.12	12.51	3.39	0.00	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	21.12	10.36	0.83	0.00	0.00
retina, adult, pool1	10030-101E3	72.16	65.50	4.47	0.60	0.10
retinoblastoma cell line:Y79	10475-106I7	24.68	1.04	0.00	0.00	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	40.20	2.70	3.44	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	28.40	11.53	0.84	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	34.86	62.90	1.52	0.00	0.00
salivary acinar cells, donor1	11771-123I7	37.07	44.02	2.43	0.81	0.16
salivary acinar cells, donor2	11772-123I8	28.91	102.30	3.17	1.79	0.55
salivary acinar cells, donor3	11773-123I9	35.09	83.42	6.62	0.00	0.00
salivary gland, adult, pool1	10093-102C3	36.03	88.08	0.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	24.53	16.53	0.93	0.08	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	29.04	15.16	0.94	0.00	0.24
seminal vesicle, adult	10201-103F3	40.74	111.10	4.23	1.59	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	33.28	10.93	4.13	0.49	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	34.22	48.56	1.76	0.50	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	31.11	24.08	5.02	1.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	40.97	42.85	3.63	0.40	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	34.93	16.14	2.32	0.11	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	29.55	19.48	0.90	0.00	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	24.83	7.09	0.71	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	21.35	11.27	0.96	0.00	0.12
skeletal muscle, fetal, donor1	10066-101I3	15.08	25.13	2.01	1.01	0.00
skin, adult, donor1	10074-102A2	40.71	74.64	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	41.03	44.19	2.52	0.00	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	63.70	22.35	3.67	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	39.72	41.29	2.52	0.95	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	81.15	3.85	32.19	0.77	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	30.99	13.02	2.14	0.00	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	17.05	9.01	3.22	0.16	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	32.03	78.23	2.62	0.00	0.22
small intestine, adult, pool1	10024-101D6	73.82	166.50	2.39	0.60	0.36
small intestine, fetal, donor1	10064-101I1	77.15	160.69	4.67	1.72	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	45.65	133.87	1.03	4.10	2.56
smooth muscle, adult, pool1	10048-101G3	55.05	166.96	1.81	0.78	1.03
somatostatinoma cell line:QGP-1	10781-110G7	30.82	25.19	2.95	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	54.60	25.69	18.81	0.46	0.69
spinal cord, adult, donor10252	10159-103A6	37.85	30.36	5.91	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	14.53	22.14	2.77	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	71.35	56.10	9.15	0.61	1.22
spinal cord, newborn, donor10223	10359-105E8	32.14	41.33	12.40	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	65.27	79.16	6.72	0.15	0.45
spleen, adult, pool1	10025-101D7	33.48	39.43	1.76	0.00	0.00
spleen, fetal, pool1	10044-101F8	35.04	56.02	3.26	0.08	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	17.91	7.97	1.55	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	20.32	7.60	1.14	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	57.31	22.71	4.89	2.10	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	31.27	9.77	2.35	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	25.33	19.81	0.68	0.00	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	25.42	5.51	5.08	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	42.31	8.04	2.54	0.00	0.42
stomach, fetal, donor1	10062-101H8	49.13	132.43	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	35.32	68.36	3.99	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	41.13	19.52	6.02	0.21	0.00
substantia nigra, adult, donor10258	10371-105G2	60.52	31.04	27.93	1.55	0.52
substantia nigra, newborn, donor10223	10358-105E7	21.20	20.49	12.72	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	39.66	16.51	2.52	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	226.42	35.69	21.79	0.68	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	91.88	14.96	18.52	0.71	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	70.33	19.34	27.25	0.88	0.00
tenocyte, donor1	11763-123H8	39.45	69.47	3.14	1.05	1.40
tenocyte, donor2	11765-123I1	24.42	67.91	0.38	0.76	1.53
tenocyte, donor3	11768-123I4	37.81	59.31	1.85	2.59	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	50.48	6.46	9.52	0.17	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	31.75	10.64	3.39	0.31	0.15
teratocarcinoma cell line:PA-1	10807-111A6	59.36	28.83	8.99	0.31	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	32.24	52.43	7.74	0.38	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	24.20	24.58	9.45	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	10.36	57.15	1.20	0.22	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	29.96	12.70	2.93	0.33	0.65
testis, adult, pool1	10026-101D8	56.26	72.15	5.58	0.54	0.21
testis, adult, pool2	10096-102C6	87.51	55.93	9.02	0.90	0.90
thalamus - adult, donor10196	10168-103B6	68.45	54.10	33.12	0.00	0.00
thalamus, adult, donor10252	10154-103A1	99.71	20.79	13.28	0.63	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	84.68	40.03	20.02	1.54	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	106.55	40.02	44.47	1.98	0.33
thalamus, newborn, donor10223	10366-105F6	41.42	39.12	17.83	2.30	0.58
throat, adult	10209-103G2	33.71	52.18	1.75	0.50	0.25
throat, fetal, donor1	10061-101H7	49.97	35.96	3.05	0.91	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	19.48	7.35	3.58	0.00	0.00
thymus, adult, pool1	10027-101D9	27.94	5.47	1.29	0.30	0.00
thymus, fetal, pool1	10043-101F7	33.35	14.13	2.08	0.10	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	26.33	12.90	1.73	0.53	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	44.84	25.00	3.49	0.56	0.28
thyroid, adult, pool1	10028-101E1	58.97	40.50	3.64	0.28	0.09
thyroid, fetal, donor1	10060-101H6	57.74	56.95	7.65	0.53	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	40.04	58.51	0.00	0.00	0.00
tongue, adult	10203-103F5	34.19	42.33	3.49	1.40	0.93
tongue, fetal, donor1	10059-101H5	33.89	33.50	0.39	0.39	1.18
tonsil, adult, pool1	10047-101G2	42.47	40.97	2.40	0.30	0.10
trachea, adult, pool1	10029-101E2	46.87	51.12	3.52	0.08	0.33
trachea, fetal, donor1	10058-101H4	34.62	53.47	1.54	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	38.97	66.96	5.67	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	33.74	8.71	1.93	0.10	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	15.20	3.45	0.94	0.00	0.00
tridermal teratoma cell line:HGRT	10694-109G1	55.17	30.44	13.32	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	26.58	40.38	1.10	0.00	0.08
umbilical cord, fetal, donor1	10057-101H3	31.30	89.72	2.09	0.00	2.09
uterus, adult, pool1	10100-102D1	39.93	216.02	3.41	0.51	0.51
uterus, fetal, donor1	10055-101H1	55.80	117.74	3.07	0.51	1.02
vagina, adult	10204-103F6	38.77	54.28	7.11	0.65	0.00
vein, adult	10191-103E2	23.67	42.96	1.53	1.32	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	23.23	4.54	1.07	0.00	0.00